Decline is not inevitable.
A daily, evidence-graded view of everything moving in kidney research : the drugs that slow decline, the science of regeneration, and the mind-body work.
A new drug may slow kidney decline in people with specific scarring.
-
Global data suggests that low physical activity is linked to a higher burden of chronic diseases, including kidney issues.
The most important news today is a strong result for a drug called finerenone. It showed promise in slowing kidney damage for a specific group of patients. Other items covered general stone prevention and the link between inactivity and disease.
Finerenone in Patients with Focal Segmental Glomerulosclerosis.
This large trial tested a drug called finerenone in 1,584 people with a specific type of kidney scarring. The drug slowed the decline of kidney function over 32 months. This is a strong result from a big, well-run study. It suggests this drug can help protect kidneys in this group.
ADVANCES IN NEPHROPROTECTIVE THERAPY IN CHRONIC KIDNEY DISEASE: THE ROLE OF SGLT2 INHIBITORS AND FINERENONE
This review summarizes large trials showing that SGLT2 inhibitors and finerenone protect the kidneys. These drugs slow kidney decline and lower heart risks. The evidence is strong because it comes from big, well-run studies.
Fragilidade e dependência funcional em idoso dialítico
This review looked at many studies about older adults on dialysis. It found a strong link between frailty and losing the ability to do daily tasks. Frailty is a state of weakness that makes people more likely to fall or get sick. This review summarizes existing evidence, so it is a strong summary of what is known.
Early proteinuria reduction as a predictor of long-term renal outcomes in lupus nephritis: A systematic review and meta-analysis.
This meta-analysis pooled data from many studies on lupus nephritis. It found that a drop in urine protein early on is a strong predictor of long-term kidney health. This is a high-level review of existing evidence. It helps doctors know which patients are at higher risk for kidney failure.
[Urinary stone prevention: non-surgical options].
This review summarizes ways to prevent kidney stones without surgery. It covers diet, fluid intake, and certain medicines. It explains how to lower the risk of stones forming. This is a general guide, not a test of a new drug.
Spatiotemporal Distribution and Projections to 2050 of the Disease Burden of Early-Onset Chronic Diseases Attributable to Low Physical Activity: A Global Burden of Disease Study.
This study used global data to estimate how much lack of exercise causes chronic disease. It looked at cancer, heart disease, diabetes, and kidney disease in young adults. It projects how this burden will grow by 2050. It shows a link between inactivity and disease, not proof of cause.
Assessment of serum 25-hydroxyvitamin D, insulin-like growth factor 1, malnutrition-inflammation score, and gene expression of VDR and IGFBP-3 in patients with diabetic nephropathy
This study looked at blood levels of vitamin D and other markers in people with diabetic kidney disease. It found links between these markers and the disease. This is an observational study, so it shows a link, not proof of cause.
КЛАСТЕРЫ КОМОРБИДНОСТИ И БИОМАРКЕРЫ ФИБРОЗА МИОКАРДА (ГАЛЕКТИН-3 И SST2) ПРИ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ С СОХРАНЕННОЙ ФРАКЦИЕЙ ВЫБРОСА: СВЯЗЬ С КЛИНИЧЕСКИМ ТЕЧЕНИЕМ
This review looks at heart failure and kidney disease. It discusses how certain blood markers might show heart scarring. This is a review of existing data, so it shows links, not proof of cause.
Comparative risk of acute kidney injury in oncology patients receiving vancomycin monotherapy versus vancomycin with piperacillin-tazobactam: a retrospective cohort study
This study looked at cancer patients taking two common antibiotics. It compared taking vancomycin alone versus taking it with piperacillin-tazobactam. The study is observational, so it shows a link but not proof of cause. It helps doctors weigh the risk of kidney injury from these drugs.
Association of acetylcholinesterase inhibitor use with short- and long-term mortality in critically ill patients with acute kidney injury: a retrospective cohort study
This study looked at people in the ICU who had sudden kidney injury. It checked if a certain type of drug was linked to survival. The study is observational, so it shows a link, not proof of cause. It does not say the drug works for everyone.
External validation of the International IgA Nephropathy Prediction Tool in Chinese patients: assessing model performance and the impact of crescents
This study tested a scoring tool for a specific kidney disease called IgA nephropathy. It used data from 998 patients in China. The tool helps doctors guess how fast the disease might get worse. This is an observational check, not a test of a new treatment.
Development and external validation of a prediction model for sepsis-associated acute kidney injury: a two-centre retrospective cohort study
This study built a tool to predict kidney injury from sepsis. It used data from 1,874 adults. The tool helps doctors spot risk early. This is an observational study, so it shows a link, not proof of cause.
Urinary peptidomic classifier for the non-invasive diagnosis of Alport syndrome
Researchers tested a new urine test for Alport syndrome. This is a rare inherited kidney disease. The test looked at 165 people with the disease and compared them to others. It showed a link between specific urine markers and the disease, but it is not yet a proven diagnostic tool.
Assessment of Nutritional Status among Patients with Chronic Kidney Disease (CKD) in a Tertiary Hospital in Kamrup (M), Assam
This study looked at the nutrition of 150 people with chronic kidney disease. It found that many of them had poor nutritional status. This is an observational study, so it shows a link, not proof of cause.
Early renal adaptation after living kidney donation assessed by multiparametric MRI
Researchers used MRI scans to watch how the remaining kidney changes after a person donates one. They followed 13 donors for 12 months. This study shows how the kidney adapts over time, but it is an observational study, not a test of a new treatment.
Thyroid dysfunction in patients undergoing hemodialysis treatment at Rafsanjan Ali-Ibn Abi-Talib Hospital in 2018
This study checked how often thyroid problems happen in people on dialysis. It found that many of these patients had thyroid issues. This is an observational study, so it shows a link, not proof of cause.
Demographic, Social, and Clinical Factors Associated with Kidney Cancer Treatment Delays in Puerto Rico, 2023-2025
This study looked at 91 kidney cancer patients in Puerto Rico. It found that some people waited a long time to start treatment. This is an observational study, so it shows a link, not proof of cause.
Occult kidney dysfunction despite preserved creatinine-based kidney function in older adults: a two-cohort study of clinical characteristics and mortality risk
This study followed 9,316 adults aged 65 and older. It found that some people have worse kidney function than their standard blood tests show. This hidden decline is linked to a higher risk of death. The study is observational, so it shows a link, not proof of cause.
Incidence of Contrast-Associated Acute Kidney Injury Following Contrast-Enhanced Computed Tomography in a Tertiary Care Hospital: A Retrospective Observational Study
This study looked at patients who had CT scans with dye. It measured how often their kidneys were injured afterward. The study is observational, so it shows a link but not proof of cause. It helps doctors understand the risk of contrast dye.
Absence of pre-dialysis nephrology care before kidney failure among patients receiving maintenance hemodialysis in Ouagadougou, Burkina Faso: frequency, associated characteristics and mode of initiation
This study looked at people in Burkina Faso who started dialysis. It found that many did not see a kidney doctor before their kidneys failed. This is an observational study, so it shows a link, not proof of cause.